This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells.
Chemotherapy is currently the…
ALKBH3 regulates glycolysis and doxorubicin resistance in triple negative breast cancer
